Problems
- High turnover of injectors/practitioners, particularly the best trained and busiest providers
- Expensive patient marketing that often leads to patient loyalty to the practitioner rather than the business
- Continual capital equipment investment
- Suboptimal prescription product pricing
- Difficulty generating long term equity